Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022), Clone: [CR3022], Human, Monoclonal

Produktübersicht

• Artikelname: Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022), Clone: [CR3022], Human, Monoclonal
• Artikelnummer: ABI-10-2004
• Hersteller Artikelnummer: 10-2004
• Alternativnummer: ABI-10-2004-100UG
• Hersteller: Abeomics
• Wirt: Human
• Kategorie: Antikörper
• Applikation: ELISA, FA
• Immunogen: Tissue, cells or virus corresponding to Human coronavirus SARS-CoV-2 Spike Glycoprotein S1. The original monoclonal antibody was generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
• Alternative Synonym: COVID19, NCOV, COV-2, COV2, COVID, SARS-COV, SARS-COV-2, COVID-19, CORONA

Produktbeschreibung

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, dipeptidyl peptidase-4, APN, aminopeptidase N, CEACAM, ca

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [CR3022]
• Isotyp: Human IgG1 kappa
• UniProt: P0DTC2
• Puffer: 0.5 mg/ml, 100 µg in sterile PBS
• Reinheit: Affinity purified
• Formel: 0.5 mg/ml, 100 ug in sterile PBS
• Target-Kategorie: Spike S1